基于肠道菌群变化研究电针对慢传输型便秘的干预作用

注册号:

Registration number:

ITMCTR2024000261

最近更新日期:

Date of Last Refreshed on:

2024-08-19

注册时间:

Date of Registration:

2024-08-19

注册号状态:

Registration Status:

补注册

Retrospective registration

注册题目:

基于肠道菌群变化研究电针对慢传输型便秘的干预作用

Public title:

Studying the Intervention Effect of Electrical Stimulation on Slow Transit Constipation Based on Changes in Gut Microbiome

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于肠道菌群变化研究电针对慢传输型便秘的干预作用

Scientific title:

Studying the Intervention Effect of Electrical Stimulation on Slow Transit Constipation Based on Changes in Gut Microbiome

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

2021ZY024250

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

陶美

研究负责人:

张俊君

Applicant:

TaoMei

Study leader:

zhangjunjun

申请注册联系人电话:

Applicant telephone:

18883370595

研究负责人电话:

Study leader's telephone:

18108395950

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1140262514@qq.com

研究负责人电子邮件:

Study leader's E-mail:

77308035@qq.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

巴南区中医院

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

重庆市巴南区龙洲湾街道龙德路20号

研究负责人通讯地址:

重庆市巴南区龙洲湾街道龙德路20号

Applicant address:

No. 20, Longde Road, Longzhouwan Street, Banan District, Chongqing

Study leader's address:

No. 20, Longde Road, Longzhouwan Street, Banan District, Chongqing

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

巴南区中医院

Applicant's institution:

Banan Hospital of Traditional Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

BNZYY202101

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件

批准本研究的伦理委员会名称:

重庆市巴南区中医院伦理委员会

Name of the ethic committee:

Ethics Committee of Banan District Hospital of Traditional Chinese Medicine, Chongqing

伦理委员会批准日期:

Date of approved by ethic committee:

2021/4/25 0:00:00

伦理委员会联系人:

孙勇

Contact Name of the ethic committee:

SunYong

伦理委员会联系地址:

重庆市巴南区龙洲湾街道龙德路20号

Contact Address of the ethic committee:

No. 20, Longde Road, Longzhouwan Street, Banan District, Chongqing

伦理委员会联系人电话:

Contact phone of the ethic committee:

13452999472

伦理委员会联系人邮箱:

Contact email of the ethic committee:

469121929@qq.com

研究实施负责(组长)单位:

巴南区中医院

Primary sponsor:

Banan District Hospital of Traditional Chinese Medicine, Chongqing

研究实施负责(组长)单位地址:

重庆市巴南区中医院

Primary sponsor's address:

No. 20, Longde Road, Longzhouwan Street, Banan District, Chongqing

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

重庆市

市(区县):

巴南区

Country:

China

Province:

Chongqing Municipality

City:

Banan District

单位(医院):

重庆市巴南区中医院

具体地址:

重庆市巴南区龙洲湾街道龙德路20号

Institution
hospital:

Banan District Hospital of Traditional Chinese Medicine, Chongqing

Address:

No. 20, Longde Road, Longzhouwan Street, Banan District, Chongqing

经费或物资来源:

科委联合项目+单位自筹

Source(s) of funding:

The joint project of the Science and Technology Commission + the unit is self-funded

研究疾病:

慢传输型便秘

研究疾病代码:

Target disease:

Slow transit constipation

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

其它

Others

研究目的:

本研究拟以电针干预STC患者,观察干预后STC患者肠道菌群变化,旨在探讨针灸与STC肠道微生态的关系。推广中医物理疗法在结直肠慢性疾病方面的应用。

Objectives of Study:

This study intends to observe the changes of intestinal flora in patients with STC after intervention by electroacupuncture, in order to explore the relationship between acupuncture and intestinal microecology of STC. To promote the application of traditional Chinese physiotherapy in chronic colorectal diseases.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

①符合上述STC诊断标准及中医辨证标准;②年龄18~70岁;③既往未行腹部及盆腔手术;④充分理解研究内容、研究风险并签署知情同意书者。

Inclusion criteria

① Meet the above STC diagnostic criteria and TCM syndrome differentiation criteria; ② Age 18 ~ 70 years old; ③ No abdominal or pelvic surgery had been performed; (4) Fully understand the research content, research risks and sign the informed consent.

排除标准:

①出口梗阻型或混合型便秘患者;②合并严重心、脑、肾、精神疾病及过敏体质者;③既往长期使用缓泻剂、阿片类药物等;④拒绝接受针灸治疗;⑤妊娠及哺乳期妇女。

Exclusion criteria:

① Patients with outlet obstruction or mixed constipation; (2) Patients with severe heart, brain, kidney, mental diseases and allergies; ③ Long-term use of laxatives, opioids, etc.; ④ refuse to accept acupuncture treatment; ⑤ Pregnant and lactating women.

研究实施时间:

Study execute time:

From 2022-01-01

To      2023-12-31

征募观察对象时间:

Recruiting time:

From 2022-01-01

To      2023-12-31

干预措施:

Interventions:

组别:

聚乙二醇组

样本量:

30

Group:

Polyethylene glycol group

Sample size:

干预措施:

口服聚乙二醇4000散(10g/袋),10g bid,连续治疗5d。

干预措施代码:

Intervention:

Oral PEG4000 powder (10g/ bag), 10g bid, continuous treatment for 5 days

Intervention code:

组别:

益生菌组

样本量:

30

Group:

probiotics

Sample size:

干预措施:

口服双歧杆菌三联活菌肠溶胶囊(0.21g/粒) 4粒 bid;连续服用5d。

干预措施代码:

Intervention:

Oral bifidobacterium triple viable enteric capsule (0.21g/ capsule) 4 capsules bid; Take it for 5 days.

Intervention code:

组别:

电针组

样本量:

30

Group:

Electroacupuncture se

Sample size:

干预措施:

选用双侧天枢、上巨虚、足三里等穴位。采用补法,将单侧天枢与足三里穴位连接于针灸治疗仪,采用疏密波型,频率15~25Hz,电流0.1mA,留针15min,每日一次。连续治疗5d。

干预措施代码:

Intervention:

Points such as bilateral Tianshu, Shangjuxu and Zusanli were selected. The single-side Tianshu and Zusanli acupoints were connected to the acupuncture treatment instrument by the method of complementing. The frequency was 15 ~ 25Hz, the current was 0.1mA, and the needle was retained for 15min, once a day. Continuous treatment for 5 days.

Intervention code:

样本总量 Total sample size : 90

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

重庆市

市(区县):

巴南区

Country:

China

Province:

Chongqing Municipality

City:

Banan District

单位(医院):

重庆市巴南区中医院

单位级别:

二级甲等

Institution/hospital:

Banan District Hospital of Traditional Chinese Medicine, Chongqing

Level of the institution:

Second class A

测量指标:

Outcomes:

指标中文名:

便秘Wexner评分

指标类型:

次要指标

Outcome:

Constipation Wexner score

Type:

Secondary indicator

测量时间点:

干预前后

测量方法:

比较3组干预前、后便秘Wexner评分,总分最低分0分,最高分30分。

Measure time point of outcome:

Before and after intervention

Measure method:

The Wexner scores of the 3 groups before and after intervention were compared, with the lowest score of 0 and the highest score of 30.

指标中文名:

便秘症状

指标类型:

次要指标

Outcome:

Constipation symptom

Type:

Secondary indicator

测量时间点:

干预前后

测量方法:

根据《便秘中医诊疗专家共识意见(2017)》中对便秘的疗效标准,实验过程中观察并记录各组受试者各项便秘症状主要评分,比较各组受试者的中医症候疗效

Measure time point of outcome:

Before and after intervention

Measure method:

According to the efficacy criteria for constipation in the Expert Consensus on TCM Diagnosis and Treatment of Constipation (2017), the main scores of constipation symptoms of subjects in each group were observed and recorded during the experiment, and the efficacy of TCM symptoms of subjects in each group was compared

指标中文名:

安全性指标

指标类型:

副作用指标

Outcome:

Safety index

Type:

Adverse events

测量时间点:

干预前后

测量方法:

①一般生命体征观察(包括血压、呼吸、体温、脉搏)。 ②随时监测不良反应(包括发生、持续的时间、症状、程度),针对不良反应行相关检查及处理。 ③监测患者试验前、试验后肝肾功、心电图。

Measure time point of outcome:

Before and after intervention

Measure method:

General vital signs observation (including blood pressure, breathing, body temperature, pulse). (2) Monitor adverse reactions (including occurrence, duration, symptoms, and degree) at any time, and conduct relevant examinations and treatments for adverse reactions. ③ Liver and kidney function and electrocardiogram were monitored before and after the test.

指标中文名:

生存质量自评量表(PAC-QOL)评分

指标类型:

次要指标

Outcome:

Quality of Life Self-Rating Scale (PAC-QOL) score

Type:

Secondary indicator

测量时间点:

干预前后

测量方法:

根据自身真实感受对表中28个问题选择相应的程度、频率选项,由轻至重计1~4分,比较3组干预前、后生存质量自评量表(PAC-QOL)评分。

Measure time point of outcome:

Before and after intervention

Measure method:

According to their real feelings, the corresponding degree and frequency of the 28 questions in the table were selected, with 1-4 points from light to heavy, and the PAC-QOL scores of the three groups were compared before and after intervention

指标中文名:

肠道微生态研究

指标类型:

主要指标

Outcome:

Study on intestinal microecology

Type:

Primary indicator

测量时间点:

干预前后

测量方法:

比较三组干预前后肠道菌群变化

Measure time point of outcome:

Before and after intervention

Measure method:

The changes of intestinal flora before and after intervention were compared among the three groups

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血清

组织:

Sample Name:

Serum

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

标本中文名:

粪便

组织:

Sample Name:

excrement

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

结束

Completed

年龄范围:

最小 18
Min age years
最大 70
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

选取2022年1月-2023年12月我院确诊及招募的STC患者90例。通过计算机分配方式随机将其分为电针组(女12例,男18例)、聚乙二醇组(女14例,男16例)及益生菌组(女18例,男12例)各30例。

Randomization Procedure (please state who generates the random number sequence and by what method):

A total of 90 patients with STC diagnosed and recruited in our hospital from January 2022 to December 2023 were selected. They were randomly divided into electroacupuncture group (12 females, 18 males), polyethylene glycol group (14 females, 16 males) and probiotic group (18 females, 12 males) with 30 cases each.

盲法:

Blinding:

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

http://www.medresman.org.cn/uc/index.aspx

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

http://www.medresman.org.cn/uc/index.aspx

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病历记录表

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Case Record Form, CRF

数据管理委员会:

Data Managemen Committee:

Yes

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

国际传统医学临床试验注册平台 京ICP备07032215号-5 提示:推荐使用IE8.0以上版本 宽屏显示分辨率下使用系统